Literature DB >> 7719464

Stereoselective pharmacokinetics of dihydropyridine calcium antagonists.

Y Tokuma1, H Noguchi.   

Abstract

Many dihydropyridine calcium antagonists are widely used for the treatment of angina and hypertension, and many more are under development. Most of these drugs have one or more chiral centre, and the pharmacological activity between the enantiomers for these drugs is known to be markedly different. First, the stereospecific assay methods for these drugs in plasma or serum are reviewed with emphasis on chiral stationary phase high-performance liquid chromatography for their determination. Next, the stereoselective pharmacokinetics of these drugs (nilvadipine, nitrendipine, felodipine, nimodipine, manidipine, benidipine and nisoldipine) in animals, healthy subjects and patients with hepatic disease is reviewed. Enantiomer-enantiomer interaction, enantiomeric inversion and the stereochemical aspects of pharmacokinetic drug interactions in these drugs are also described.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719464     DOI: 10.1016/0021-9673(94)00832-t

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

Review 1.  Bioequivalence of controlled-release calcium antagonists.

Authors:  R Schall; F R Müller; F O Müller; H G Luus
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

2.  The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.

Authors:  Daniel Paris; Ghania Ait-Ghezala; Corbin Bachmeier; Gary Laco; David Beaulieu-Abdelahad; Yong Lin; Chao Jin; Fiona Crawford; Michael Mullan
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

3.  Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine.

Authors:  J Vincent; S I Harris; G Foulds; L C Dogolo; S Willavize; H L Friedman
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

Review 4.  Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.

Authors:  H D Langtry; C M Spencer
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.